-+ 0.00%
-+ 0.00%
-+ 0.00%

Adial submits AD04 application for FDA Commissioner's National Priority Voucher pilot program

PUBT·04/27/2026 12:47:15
Listen to the news
Adial submits AD04 application for FDA Commissioner's National Priority Voucher pilot program
  • Adial Pharmaceuticals submitted an application to FDA Commissioner’s National Priority Voucher (CNPV) pilot program for its AD04 development program.
  • CNPV, if granted, could allow an accelerated FDA review timeline of about 1-2 months once complete materials are submitted, versus standard 10-12 months.
  • Voucher, if awarded, cannot be transferred or sold.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adial Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604270847PRIMZONEFULLFEED9696612) on April 27, 2026, and is solely responsible for the information contained therein.